Diversify Wealth Management LLC cut its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 86.2% in the fourth quarter, Holdings Channel reports. The institutional investor owned 1,674 shares of the conglomerate’s stock after selling 10,474 shares during the quarter. Diversify Wealth Management LLC’s holdings in Danaher were worth $394,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in DHR. JPL Wealth Management LLC acquired a new stake in Danaher in the 3rd quarter valued at $25,000. Elevated Capital Advisors LLC acquired a new position in Danaher during the fourth quarter worth $26,000. WFA of San Diego LLC purchased a new position in Danaher during the second quarter valued at $26,000. ANTIPODES PARTNERS Ltd purchased a new position in Danaher during the third quarter valued at $27,000. Finally, Financial Life Planners acquired a new stake in shares of Danaher in the third quarter valued at about $32,000. 79.05% of the stock is owned by institutional investors and hedge funds.
Danaher Trading Down 0.1%
Shares of Danaher stock opened at $170.98 on Monday. Danaher Corporation has a 1-year low of $170.74 and a 1-year high of $242.80. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The stock has a market cap of $121.01 billion, a P/E ratio of 33.07, a P/E/G ratio of 2.29 and a beta of 0.81. The stock’s 50 day simple moving average is $191.25 and its 200-day simple moving average is $212.54.
Danaher Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher’s payout ratio is 30.95%.
Analysts Set New Price Targets
Several research analysts recently weighed in on the stock. JPMorgan Chase & Co. reduced their price target on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Wolfe Research lowered their price objective on Danaher from $260.00 to $230.00 and set an “outperform” rating on the stock in a report on Wednesday, April 8th. UBS Group cut their price objective on Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. KeyCorp reissued an “overweight” rating on shares of Danaher in a report on Thursday, January 29th. Finally, Argus decreased their target price on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. Eighteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $240.70.
Insiders Place Their Bets
In other news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares of the company’s stock, valued at $1,060,642.99. This represents a 20.56% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 10.80% of the stock is owned by insiders.
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Read More
- Five stocks we like better than Danaher
- Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum
- Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major Players
- Flutter Sees Post-Earnings Boost as FanDuel Shows Signs of Recovery
- 3 Healthcare Stocks Set to Benefit From the One Big Beautiful Bill
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
